Table 3 Baseline characteristics of two groups
From: Immune checkpoint inhibitor-related myocarditis in patients with lung cancer
Characteristics | Control group(n) No. (%) | Myocarditis group No. (%) | P Value |
|---|---|---|---|
Age (year) | 65.92 ± 8.52 | 64.55 ± 8.02 | 0.341 |
Body mass index (kg/m2) | 23.68 ± 3.64 | 23.82 ± 2.73 | 0.811 |
Sex | Â | Â | 0.039 |
 Male | 59 (89.4) | 50(75.8) |  |
 Female | 7(10.6) | 16(24.2) |  |
Smoking history | Â | Â | 0.201 |
 No | 11(16.7) | 17(25.8) |  |
 Yes | 55(83.3) | 49(74.2) |  |
Drinking history | Â | Â | 0.008 |
 No | 21(31.8) | 36(54.5) |  |
 Yes | 45(68.2) | 30(45.5) |  |
Pathological type | Â | Â | 0.017 |
 NSCLC | 55(83.3) | 43(65.2) |  |
 SCLC | 11(16.7) | 23(34.8) |  |
Types of ICI | Â | Â | 0.024 |
 PD-1 | 59(89.4) | 49(74.2) |  |
 PD-L1 | 7(10.6) | 17(25.8) |  |
ICI combination | Â | Â | 0.367 |
 No | 14(21.2) | 10(15.2) |  |
 Yes | 52(78.8) | 56(84.8) |  |
Cardiovascular history | Â | Â | 0.601 |
 No | 33(50.0) | 30(45.5) |  |
 Yes | 33(50.0) | 36(54.5) |  |
History of diabetes | Â | Â | 0.627 |
 No | 54(81.8) | 57(86.4) |  |
 Yes | 11(18.2) | 9(13.6) |  |